By proceeding, you agree to our Terms of Use and Privacy Policy.
Dr. Nancy Tawil, M. Eng, Ph.D, is the Chief Scientific Officer at Phagelux Inc., a platform company specializing in the use of bacteriophages and endolysins as a way of combating bacterial and multi-drug resistant infections.
Talks About #scientific #bacterialinfections #anti-infectives #
Preferred Locations #NorthAmerica
Phage therapies have shown promise in compassionate use, but limited success of double blind randomised controlled trials has slowed progression through the clinic.
